Relationships Between D-Dimer Levels and Stroke Risk as Well as Adverse Clinical Outcomes After Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Authors:
Open Access
- 7 June 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Abstract
Objective: Abnormal elevation of D-dimer levels is an important indicator of disseminated intravascular clotting. Therefore, we hypothesized that high D-dimer levels were associated with the risk of stroke and adverse clinical outcomes of patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).Methods: The present meta-analysis aimed to systematically analyze the associations between D-dimer and the risk of stroke as well as the clinical outcomes of patients with post-stroke or TIA. Meanwhile, dose–response analyses were conducted when there were sufficient data available. Three electronic databases including Pubmed, the Embase database, and the Cochrane Library were searched by two investigators independently. All the pooled results were expressed as risk ratios (RRs).Results: Finally, 22 prospective cohort studies were included into this meta-analysis. The results suggested that high D-dimer levels were associated with increased risks of total stroke (RR 1.4, 95%CI 1.20–1.63), hemorrhagic stroke (RR 1.25, 95%CI 0.69–2.25), and ischemic Stroke (RR 1.55, 95%CI 1.22–1.98), and the dose-dependent relationship was not found upon dose–response analyses. Besides, the high D-dimer levels on admission were correlated with increased risks of all-cause mortality [RR 1.77, 95% confidence interval (CI) 1.26–2.49], 5-day recurrence (RR 2.28, 95%CI 1.32–3.95), and poor functional outcomes (RR 2.01, 95%CI 1.71–2.36) in patients with AIS or TIA.Conclusions: On the whole, high D-dimer levels may be associated with the risks of total stroke and ischemic stroke, but not with hemorrhagic stroke. However, dose–response analyses do not reveal distinct evidence for a dose-dependent association of D-dimer levels with the risk of stroke. Besides, high D-dimer levels on admission may predict adverse clinical outcomes, including all-cause mortality, 5-day recurrence, and 90-day poor functional outcomes, of patients with AIS or TIA. More studies are warranted to quantify the effect of D-dimer levels on the risk of stroke or TIA, so as to verify and substantiate this conclusion in the future.Keywords
This publication has 41 references indexed in Scilit:
- Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling studyCritical Care, 2013
- Fibrin D-Dimer, Tissue-Type Plasminogen Activator, von Willebrand Factor, and Risk of Incident Stroke in Older MenStroke, 2012
- The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic StrokeStroke, 2012
- Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysisBMJ, 2011
- Prasugrel, a New Platelet InhibitorMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and StrokeCirculation, 2007
- D-dimer is not a long-term prognostic marker following acute cerebral ischemiaBlood Coagulation & Fibrinolysis, 2006
- Fibrin D-Dimer and Cardiovascular RiskSeminars in Vascular Medicine, 2005
- SECONDARY DEHP-METABOLITES AND HUMAN SEMEN PARAMETERSEpidemiology, 2005
- Hazard Ratio in Clinical TrialsAntimicrobial Agents and Chemotherapy, 2004